Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for fusion proteins, bcr- abl
Most Correlated Studies
- Spleens of mice transplanted with stem cells expressing fusion proteins BCR/ABL and ABL/BCR
- Progenitor B BaF3 cells with DOX-induced BCR-ABL expression in the presence or absence of IL-3
- Chronic myeloid leukemias with BCR-ABL fusions before and after imatinib mesylate treatment
- Bcl6-regulated gene expression in BCR-ABL transformed myeloid cells treated with Imatinib and RI-BPI
- Chronic myeloid leukemia (CML) K562 cells with anti-BCR-ABL shRNA knockdown
Most Relevant Literature
- Preparation and identification of rabbit polyclonal antibody against BCR-ABL b3a2 fusion protein].
- A combined computational and experimental strategy identifies mutations conferring resistance to dru…
- Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and pho…
- Generation of the induced pluripotent stem cell line KUMi001-A carrying the Philadelphia chromosome …
- Cardiovascular management of patients with chronic myeloid leukemia treated with BCR-ABL tyrosine ki…
Most Relevant Clinical Trials
- Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.
- Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromos…
- Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-AB…
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refr…
- Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Le…
